个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Liu Zheng[1,2] * ; Nie Yuxue[1] * ; Peng Yu[1] ; Lu Hui[1] ; Zhang Panpan[3] ; Li Jieqiong[4] ; Sun Ruijie[1] ; Li Jingna[1] ; Sun Boyuan[1,5] ; He Xin[1,5] ; Zhou Jiaxin[1] ; Fei Yunyun[1] ; Peng Linyi[1,*1] ; Zhang Wen[1,*1] ; Zeng Xiaofeng[1] ;
机构： [1]Department of Rheumatology, Peking Union Medical College Hospital, National Clinical Research Center for Dermatologic and Immunologic Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China [2]Department of Rheumatology, Beijing Tongren Hospital, Capital Medical University, Beijing, China [3]Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [4]Department of Internal Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China [5]M.D. Program, Peking Union Medical College, Beijing, China
出处：
DOI： 10.1016/j.semarthrit.2023.152202
ISSN：

关键词： IgG4-realted disease Criteria diagnosis

摘要：
To externally validate the performance of the 2019 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for IgG4-related disease (IgG4-RD) within a cohort from China and to compare the criteria with the 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD.This study included 875 IgG4-RD and 302 non-IgG4-RD cases (213 mimickers and 89 patients with other diseases). Using expert clinical judgment as the gold standard for diagnosis of IgG4-RD, the performance (sensitivity, specificity, area under the curve (AUC) of the 2019 ACR/EULAR criteria for IgG4-RD was evaluated. We also compared it with the 2020 RCD criteria.The 2019 ACR/EULAR classification criteria had a sensitivity of 76.6% (95% CI: 73.8% to 79.4%) and a specificity of 98.0% (96.0%-99.4%), an AUC of 0.873 (0.857-0.889) in the overall cohort. Those false negative cases under the 2019 ACR/EULAR classification criteria had significantly lower levels of serum IgG4, and fewer had pathological information, with a higher frequency in the involvement of those uncommon organs compared with the true positive cases. The cases judged as negative by the 2019 ACR/EULAR classification criteria yet judged as "definite" by the 2020 RCD criteria had more involvement of uncommon organs.The 2019 ACR/EULAR classification criteria for IgG4-RD show outstanding specificity and good sensitivity in real-world clinical practice. The 2020 RCD criteria are helpful for the diagnosis of IgG4-RD in clinical scenarios where IgG4-RD presents as involving an isolated organ, especially the unusual sites.Copyright © 2023. Published by Elsevier Inc.

基金：
National Key Research and Development Program of China (2022YFC2703104), Beijing Municipal Science & Technology Commission (No. Z201100005520022, 23, 25–27), CAMS Innovation Fund for Medical Sciences (CIFMS 2021–1-I2M-003, 2022-I2M-C&T-B-005), and National High Level Hospital Clinical Research Funding 2022-PUMCH-C-006, 2022-PUMCH-A-041, 2022- PUMCH-B-013)
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 2 区 医学
小类 | 2 区 风湿病学
最新[2023]版：
大类 | 2 区 医学
小类 | 2 区 风湿病学
JCR分区：
出版当年[2021]版：
Q2 RHEUMATOLOGY
最新[2023]版：
Q1 RHEUMATOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Department of Rheumatology, Peking Union Medical College Hospital, National Clinical Research Center for Dermatologic and Immunologic Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China [2]Department of Rheumatology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
共同第一作者：
通讯作者：
通讯机构： [1]Department of Rheumatology, Peking Union Medical College Hospital, National Clinical Research Center for Dermatologic and Immunologic Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China [*1]Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China
推荐引用方式(GB/T 7714)：
Liu Zheng,Nie Yuxue,Peng Yu,et al.The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China[J].SEMINARS IN ARTHRITIS AND RHEUMATISM.2023,61:152202.doi:10.1016/j.semarthrit.2023.152202.
APA：
Liu Zheng,Nie Yuxue,Peng Yu,Lu Hui,Zhang Panpan...&Zeng Xiaofeng.(2023).The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China.SEMINARS IN ARTHRITIS AND RHEUMATISM,61,
MLA：
Liu Zheng,et al."The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China".SEMINARS IN ARTHRITIS AND RHEUMATISM 61.(2023):152202

相关文献

[1]Proposal of new diagnostic criteria for fatal familial insomnia [2]Association of G6PD variants with hemoglobin A1c and impact on diabetes diagnosis in East Asian individuals [3]Association of G6P Dvariants with hemoglobin A1c and impact on diabetes diagnosis in East Asian individuals [4]致死性家族性失眠症中国诊断标准共识2021 [5]Obesity criteria for identifying metabolic risks [6]Evaluation of potentially inappropriate medications in older patients admitted to the cardiac intensive care unit according to the 2019 Beers criteria, STOPP criteria version 2 and Chinese criteria [7]吉兰-巴雷综合征疾病谱:用新的标准重新分类 [8]肾脏病发作概念的问世与急性肾损害分类和诊断标准更新 [9]伴眼部损害复发性多软骨炎192例临床分析及rose标准应用 [10]日间手术麻醉离院标准

资源点击量：21189 今日访问量：0 总访问量：1219 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持：重庆聚合科技有限公司 地址：北京市东城区东交民巷1号(100730)